Budge James 4
4 · Hinge Health, Inc. · Filed Feb 24, 2026
Research Summary
AI-generated summary of this filing
Hinge Health (HNGE) CFO James Budge Sells Shares
What Happened
James Budge, Chief Financial Officer of Hinge Health, sold a total of 14,763 shares in open-market transactions on February 23, 2026. The three tranches were: 7,566 shares at an average $38.74 ($293,077), 6,297 shares at an average $39.90 ($251,271), and 900 shares at an average $40.43 ($36,389), for aggregate proceeds of roughly $580,737. These were sales (not purchases) and therefore represent dispositions of stock rather than new investment.
Key Details
- Transaction date: February 23, 2026; Form 4 filed February 24, 2026 (timely filing).
- Instrument/Type: Open-market sales (code S).
- Lots and reported averages:
- 7,566 shares @ $38.74 — total $293,077 (range reported: $38.40–$39.37).
- 6,297 shares @ $39.90 — total $251,271 (range reported: $39.40–$40.39).
- 900 shares @ $40.43 — total $36,389 (range reported: $40.40–$40.46).
- Total shares sold: 14,763; total proceeds ≈ $580,737.
- Shares owned after transaction: Not disclosed in the provided filing.
- Footnotes: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted June 12, 2025 (pre-arranged plan). The filing includes weighted-average prices and ranges; the reporting person will provide a per-price breakdown to the SEC or issuer upon request.
Context
Sales executed under a Rule 10b5-1 plan are pre-scheduled dispositions and are generally treated as routine insider liquidity rather than a contemporaneous signal of view on the company. This filing shows dispositions only (no option exercises, awards, or purchases reported).
Insider Transaction Report
- Sale
Class A Common Stock
[F1][F2]2026-02-23$38.74/sh−7,566$293,077→ 427,329 total - Sale
Class A Common Stock
[F1][F3]2026-02-23$39.90/sh−6,297$251,271→ 421,032 total - Sale
Class A Common Stock
[F1][F4]2026-02-23$40.43/sh−900$36,389→ 420,132 total
Footnotes (4)
- [F1]The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
- [F2]Represents the weighted average sale price. The lowest price at which shares were sold was $38.40 and the highest price at which shares were sold was $39.37. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- [F3]Represents the weighted average sale price. The lowest price at which shares were sold was $39.40 and the highest price at which shares were sold was $40.39. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- [F4]Represents the weighted average sale price. The lowest price at which shares were sold was $40.40 and the highest price at which shares were sold was $40.46. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.